THE DEAL, AT A GLANCE
From the announcementExscientia
01Who is involvedBacked by Various (IPO)From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedExscientia raised $510M IPOFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersExscientia is positioned as an AI drug design platform with the first AI-designed drug in clinical trials and an IPO-funded plan to advance a Centaur Chemist AI pipeline…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Exscientia · Financing Record
Explore source-linked visual explanations for Exscientia. Unsupported claims are withheld while source review continues.
Record 794 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →